4.5 Article

Human Fecal Mucin Glycosylation as a New Biomarker in Inflammatory Bowel Diseases

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Biochemistry & Molecular Biology

Mucus sialylation determines intestinal host-commensal homeostasis

Yikun Yao et al.

Summary: Intestinal mucus sialylation by ST6GALNAC1 is crucial for mucus integrity and protection against bacterial degradation. ST6 mutations lead to decreased sialylation, resulting in defective mucus proteins and congenital inflammatory bowel disease. Treatment with sialylated mucin or a Foxo3 inhibitor can ameliorate the disease.
Article Multidisciplinary Sciences

Proximal colon-derived O-glycosylated mucus encapsulates and modulates the microbiota

Kirk Bergstrom et al.

SCIENCE (2020)

Review Gastroenterology & Hepatology

The role of glycosylation in IBD

Evropi Theodoratou et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2014)

Article Gastroenterology & Hepatology

Mucins in inflammatory bowel diseases and colorectal cancer

Yong H. Sheng et al.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2012)

Article Biochemical Research Methods

Expression of a Core 3 Disialyl-Lex Hexasaccharide in Human Colorectal Cancers: A Potential Marker of Malignant Transformation in Colon

Catherine Robbe-Masselot et al.

JOURNAL OF PROTEOME RESEARCH (2009)